Johnson & Johnson JNJ
NYSE JNJ
$266.68 -0.40 (-0.15%)
As of: Sep 10, 2026 · 1:23 PM EDT

Johnson & Johnson (JNJ) Goodwill (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Goodwill came in at $48.5 billion in Q2 2026, up 0.75% year-over-year from $48.1 billion in Q2 2025, and little changed quarter-over-quarter from $48.6 billion in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Goodwill (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Goodwill across 18 years of filings, most recently posting $48.5 billion for Q2 2026.

  • In Q2 2026, Goodwill rose 0.75% year-over-year to $48.5 billion; the TTM figure through Jun 2026 stood at $48.5 billion (up 0.75% YoY), while the FY2025 annual figure was $48.8 billion, up 10.34% from the prior year.
  • Goodwill came in at $48.5 billion for Q2 2026 at Johnson & Johnson, roughly flat from $48.6 billion in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $48.8 billion in Q4 2025 to a low of $25.4 billion in Q1 2022.
  • Average Goodwill over 5 years is $41.3 billion, with a median of $44.2 billion recorded in 2024.
  • Year-over-year, Goodwill plunged 30.11% in 2022 and soared 41.72% in 2023.
  • Over 5 years, Goodwill stood at $33.4 billion in 2022, then increased by 9.51% to $36.6 billion in 2023, then climbed by 20.9% to $44.2 billion in 2024, then rose by 10.34% to $48.8 billion in 2025, then slipped by 0.6% to $48.5 billion in 2026.
  • Per Business Quant data, the three most recent Goodwill figures were $48.5 billion in Q2 2026, $48.6 billion in Q1 2026, and $48.8 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 642.01 Bn 621.25 Bn 17.26 Bn
2 AbbVie 446.87 Bn 440.30 Bn 12.70 Bn
3 Merck 358.09 Bn 350.95 Bn 12.21 Bn
4 Novartis Ag 267.67 Bn 259.98 Bn 11.24 Bn
5 Pfizer 156.85 Bn 145.15 Bn 10.94 Bn
6 Sanofi 52.23 Bn 44.85 Bn 10.79 Bn
7 Revolution Medicines 43.11 Bn 43.11 Bn -
8 Incyte 24.62 Bn 20.08 Bn 1.57 Bn
9 United Therapeutics 21.29 Bn 18.62 Bn 683.80 Mn
10 Neurocrine Biosciences 15.88 Bn 15.49 Bn 935.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 48.48 Bn
Mar 29, 2026 48.56 Bn
Dec 28, 2025 48.77 Bn
Sep 28, 2025 48.05 Bn
Jun 29, 2025 48.12 Bn
Mar 30, 2025 44.47 Bn
Dec 29, 2024 44.20 Bn
Sep 29, 2024 44.80 Bn
Jun 30, 2024 44.25 Bn
Mar 31, 2024 36.62 Bn
Dec 31, 2023 36.56 Bn
Oct 1, 2023 36.12 Bn
Jul 2, 2023 45.44 Bn
Apr 2, 2023 45.58 Bn
Jan 1, 2023 36.05 Bn
Oct 2, 2022 33.38 Bn
Jul 3, 2022 34.17 Bn
Apr 3, 2022 34.94 Bn
Jan 2, 2022 25.44 Bn
Oct 3, 2021 35.57 Bn